MENU
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Viridian Therapeutics (VRDN) Earnings Date & Reports
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
VRDN is expected to report earnings to fall 6.17% to -98 cents per share on November 16
Q3'26
Est.
$-0.99
Q2'26
Missed
by $0.02
Q1'26
Beat
by $0.18
Q4'25
Beat
by $0.64
Q3'25
Beat
by $0.61
The last earnings report on August 06 showed earnings per share of -104 cents, missing the estimate of -102 cents. With 1.17M shares outstanding, the current market capitalization sits at 2.33B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a developer of biopharmaceuticals
Industry Biotechnology
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
252
Web
https://www.viridiantherapeutics.com